Prev Arrow Stocks

Quidelortho Corpoation ($QDEL) Stock Forecast: Down 5.8% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Quidelortho Corpoation?

QuidelOrtho Corporation (NASDAQ: QDEL) is a global leader in in vitro diagnostics. Today, the stock had a strong bearish movement in the market.

Why is Quidelortho Corpoation going down?

QDEL stock is down 5.8% on Oct 28, 2025 13:45

  • The release of Episode 52 of the Science Bytes podcast featuring a Senior Global Product Manager might not have resonated well with investors, possibly indicating a lack of significant positive developments or catalysts for the company.
  • Investors may have been expecting more substantial news or updates from QuidelOrtho Corporation, leading to disappointment and a bearish sentiment in the market.
  • The market might be reacting to a perceived lack of innovation or growth potential in the company's recent initiatives, causing a negative impact on QDEL's stock price.

QDEL Price Chart

QDEL Technical Analysis

QDEL News

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics - QuidelOrtho ( NASDAQ:QDEL )

SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation ( NASDAQ:QDEL ) , a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT ( ASCP ) , Senior Global Product Manager - Informatics.

https://www.benzinga.com/pressreleases/25/10/n48394833/informatics-illuminated-science-bytes-podcast-explores-the-power-behind-smarter-diagnostics

0 News Article Image Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics - QuidelOrtho  ( NASDAQ:QDEL )

Quidelortho Corpoation Price History

08.04.2025 - QDEL Stock was up 38.6%

  • QDEL stock experienced a bullish movement today.
  • The strong bullish movement can be attributed to QDEL's Q1 earnings beat and the expansion of margins.
  • Despite soft overall top-line results, the solid performances by the Labs and Immunohematology units, as well as growth in the EMEA and Other regions, contributed to the positive market sentiment.
  • Investors seem optimistic about QDEL's future prospects following the earnings and revenue surprises in the first quarter of 2025.

08.04.2025 - QDEL Stock was up 28.5%

  • QDEL showed strong bullish movement today due to the company's impressive Q1 earnings and revenue results, surpassing analyst estimates.
  • The 27.59% earnings surprise and 0.30% revenue beat have boosted investor confidence in the company's growth prospects.
  • Positive financial performance indicates high demand for QDEL's diagnostic healthcare solutions, positioning the stock well in the market.

28.09.2025 - QDEL Stock was down 5.8%

  • The release of Episode 52 of the Science Bytes podcast featuring a Senior Global Product Manager might not have resonated well with investors, possibly indicating a lack of significant positive developments or catalysts for the company.
  • Investors may have been expecting more substantial news or updates from QuidelOrtho Corporation, leading to disappointment and a bearish sentiment in the market.
  • The market might be reacting to a perceived lack of innovation or growth potential in the company's recent initiatives, causing a negative impact on QDEL's stock price.

04.05.2025 - QDEL Stock was up 7.2%

  • QDEL displayed a significant bullish movement, possibly influenced by favorable news or financial outcomes.
  • The general bullish sentiment in the market likely played a role in driving QDEL's stock price higher.
  • Despite challenges faced by other companies such as CrowdStrike during pre-market trading, QDEL's outstanding performance captured investors' attention and resulted in a surge in its stock price.
  • Investors' favorable response to QDEL's strategic moves, product advancements, or market positioning could have contributed to the positive trend in the stock.

29.06.2025 - QDEL Stock was down 5.9%

  • The urgent need for early detection in drug overdose cases may have raised concerns about the potential impact on Quidel's diagnostic testing products.
  • The evolving challenges facing emergency departments could indicate a higher demand for Quidel's products, but the bearish movement might suggest that investors are uncertain about the company's ability to meet this demand effectively.
  • The limits of Narcan could be seen as a potential limitation for Quidel's products if they are unable to provide comprehensive solutions for drug overdose detection.

02.04.2025 - QDEL Stock was up 5.2%

  • Today's bullish movement in QDEL stock can be attributed to the following factors:
  • Expectations of strong earnings growth for QDEL, with the company possessing the right ingredients for a likely earnings beat in the upcoming period.
  • Positive sentiment in the overall MedTech sector, with companies like QDEL, HIMS, GMED, and HAE expected to outshine Q1 earnings estimates.
  • Investors are likely optimistic about QDEL's performance given the overall recovery in the base business on a year-over-year basis in the MedTech industry.

21.04.2025 - QDEL Stock was down 5.1%

  • Despite QDEL's strong product portfolio and growth prospects, the stock experienced a bearish movement today.
  • Investors might have reacted to broader market trends or specific industry news, causing a sell-off in QDEL shares.
  • It's possible that profit-taking or concerns about future performance overshadowed the positive aspects.
  • Traders might be reevaluating their positions in QDEL amidst market uncertainties, leading to the bearish movement despite the company's growth potential.

07.07.2025 - QDEL Stock was down 9.8%

  • Despite a recent positive earnings report and margin expansion, QDEL experienced a strong bearish movement today.
  • Soft revenue and ongoing business headwinds may have outweighed the positive earnings beat, resulting in the bearish market movement.
  • Concerns about the sustainability of margin improvements in a challenging business environment likely triggered a sell-off of QDEL shares by investors.

30.03.2025 - QDEL Stock was down 5.1%

  • The bearish movement in QDEL stock today could be attributed to profit-taking by investors ahead of the upcoming earnings report.
  • Despite expectations of strong earnings growth, market sentiment may have been influenced by broader economic concerns or sector rotation.
  • Investors might be cautious due to uncertainties surrounding the company's future guidance or potential challenges in the healthcare industry.
  • It's possible that some traders are adjusting their positions based on short-term market dynamics rather than the long-term growth prospects of QDEL.

10.03.2025 - QDEL Stock was down 7.1%

  • The surge in QDEL's stock price might have been driven by the positive sentiment surrounding its strong product portfolio.
  • However, the bearish movement today could be attributed to profit-taking by investors after a significant surge.
  • The uncertainty regarding the stock's ability to sustain further gains due to the latest trend in earnings estimate revisions might have also contributed to the bearish movement.
  • Overall, while QDEL has shown growth potential, short-term fluctuations in the market sentiment and earnings outlook can lead to bearish movements like the one observed today.

06.05.2025 - QDEL Stock was down 5.1%

  • QDEL stock has been on a downward trend since the last earnings report, with a decline of 18%. This negative performance could be contributing to today's bearish movement.
  • The overall market sentiment seems mixed, with U.S. stock futures slightly higher and the Dow gaining around 0.1%. However, specific companies like CrowdStrike Holdings, Inc. are experiencing sharp falls after reporting their first-quarter results. This negative sentiment in the tech sector could be impacting QDEL's stock price as well.
  • Investors might be cautious about QDEL's future performance, especially considering the uncertainty surrounding earnings estimates. This uncertainty could be adding to the bearish pressure on the stock.

01.09.2025 - QDEL Stock was up 5.3%

  • Quidel Corporation (QDEL) experienced a strong bullish movement recently.
  • The launch of the FDA-approved QUICKVUE Influenza + SARS Test for professional use by QDEL has expanded its portfolio, attracting investors' attention.
  • The addition of this new test to QDEL's respiratory testing lineup is seen as a strategic move to capitalize on the ongoing demand for comprehensive diagnostic solutions, potentially driving up the stock price.
  • The market's positive reaction to this development indicates confidence in QDEL's ability to continue innovating and meeting market needs effectively.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.